News Image

Unusual volume stocks in Tuesday's session

By Mill Chart

Last update: Apr 16, 2024

Unusual volume stocks in Tuesday's session

Today's unusual volume stocks

TickerChangeComment
SNGX14.89%Today, SOLIGENIX INC (NASDAQ:SNGX) stands out with a high volume of 7.77M shares. The share price of NASDAQ:SNGX increased by 14.89% today, reflecting positive market movement. In comparison to the average daily volume of the last 50 days, the current volume is 172.0% above. This suggests a notable change in trading activity.
INDO-13.24%The trading activity for INDONESIA ENERGY CORP LTD (NYSEARCA:INDO) has surged with a volume of 5.21M shares today. NYSEARCA:INDO is declining 13.24% today. This volume is 179.0% above the average 50 day volume.
PRFX-18.37%PAINREFORM LTD's (NASDAQ:PRFX) traded a high volume of 200.54K shares. This decline in share price leads to a decrease of 18.37%. The average volume measured over 50 days is 155.49K, so this is 28.97% above the average volume.
ONVO-11.85%ORGANOVO HOLDINGS INC (NASDAQ:ONVO) has an unusual volume of 1.5M shares. The share price decreased by 11.85%. Compared to the average daily volume of the past 50 days, the current volume is 26.07% above, suggesting an unusual level of trading activity.
OMQS-24.29%OMNIQ CORP (NASDAQ:OMQS) has an unusual volume of 585.41K shares. NASDAQ:OMQS is declining 24.29% today. The average volume over the last 50 days is 419.11K, making today's volume 39.68% above the average. This signifies a notable change in market participation.
CLDI-58.47%CALIDI BIOTHERAPEUTICS INC (NYSEARCA:CLDI) has an unusual volume of 3.77M shares. The share price decreased by 58.47%. This is 645.0% above the average daily volume of the last 50 days. A press release (Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering) was released earlier today.
RCON-7.79%1.38M shares of RECON TECHNOLOGY LTD-CLASS A (NASDAQ:RCON) exchanged hands today. Shares are falling by 7.79%. This volume is 90.82% above the average 50 day volume.
PRZO-20.42%The trading volume of PARAZERO TECHNOLOGIES LTD (NASDAQ:PRZO) today is 12.14M shares, which is considered unusual. The share price decreased by 20.42%. The average volume over the last 50 days is 1.17M, making today's volume 936.0% above the average. This signifies a notable change in market participation. Earlier today the company had a press release: ParaZero Develops Counter Drone Solutions Leveraging Its Unique Technology.
HUSA-12.04%Today's trading session witnessed an unusual volume of 1.7M shares for HOUSTON AMERICAN ENERGY CORP (NYSEARCA:HUSA). The price decline of 12.04% reflects a downward movement in NYSEARCA:HUSA shares. This is 195.0% above the average daily volume of the last 50 days.
MRNS-1.54%Today's trading session witnessed an unusual volume of 12.41M shares for MARINUS PHARMACEUTICALS INC (NASDAQ:MRNS). The share price decreased by 1.54%. The average daily volume over the past 50 days is 1.17M. Hence, the current volume is 959.0% above the average volume, indicating a deviation from the usual trading pattern. Yesterday the company had a press release: Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results.

To see the full list of unusual volume stocks you can use our unusual volume stocks screener.

Back

ORGANOVO HOLDINGS INC

NASDAQ:ONVO (5/3/2024, 7:10:24 PM)

After market: 1.02 -0.01 (-0.97%)

1.03

+0.08 (+8.38%)

ONVO News

News Image18 days ago - ChartmillUnusual volume stocks in Tuesday's session

Unusual volume stocks in Tuesday's session

News Image19 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

News Image19 days ago - ChartmillCurious about the most active stocks on Monday? Find out which stocks are dominating the market action!

Activity analysis on 2024-04-15: most active stocks in today's session.

News Image20 days ago - ChartmillGapping stocks in Monday's session

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

News Image20 days ago - ChartmillThese stocks are moving in today's pre-market session

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

News Image20 days ago - Organovo, Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
News Image20 days ago - Organovo, Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat...

News Image3 months ago - Seeking AlphaOrganovo files for $150M mixed shelf (NASDAQ:ONVO)

Organovo (NASDAQ:ONVO) disclosed in an SEC filing on Friday a prospectus to offer and sell common stock, preferred stock, debt securities, warrants, units...

News Image3 months ago - Organovo, Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
News Image3 months ago - Organovo, Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress

SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing FXR314...

News Image4 months ago - Organovo, Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
News Image4 months ago - Organovo, Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress

SAN DIEGO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is focused on developing...

ONVO Links
Follow us for more